Farms.com Home   News

Livestock Health: mRNA Vaccine vs Conventional Vaccines

By Dr. Lew Strickland

A couple of months ago a video was posted on social media that messenger RNA (mRNA) vaccine technology was being used on cattle. Of course, this was and is false information, but did raise multiple concerns and statements were released from NCBA to confirm that this technology is not being used on cattle. These statements also confirmed that a mRNA vaccine is not approved for use in cattle, and this type of vaccine is not even commercially available for use. I even received questions on this topic at some of the Master Beef meetings that occurred around that time. With concerns such as these, it would be a good time to cover some of the basics of vaccines so that you can have an understanding if you are approached with questions.

Modified-live virus vaccines (MLV)

MLV vaccines contain a weakened or attenuated form of a live virus (antigen). Because the virus has been altered, it should not cause clinical disease, but will very closely mimic a true infection.

Once the vaccine is administered, the virus will replicate within the animal’s system and create the opportunity for an immune response through the production of antibodies. These antibodies then respond to fight infection if exposed to the natural virus later. A MLV vaccine will typically come packaged as two separate bottles that require mixing.

crop

Killed Vaccines

Killed vaccines contain an inactivated, or killed, antigen that is incapable of replicating in the animal’s system. Because the killed virus does not have that opportunity to replicate, killed vaccines usually require a booster dose. The killed vaccine requires more viral antigen, or pieces of the virus, to get enough immune system recognition after administration, and is prepared with an adjuvant to create an immune response. Typically, killed vaccines are packaged as a single bottle.

crop

mRNA Vaccines

mRNA vaccines are a relatively new type of vaccine. An example of an mRNA technology vaccine is the COVID-19 vaccine. The vaccine contains genetic material, the messenger RNA, which tells the body how to make a protein. mRNA then provides a recipe that cells can use to make proteins. After injection, the cells in the muscle pick up the mRNA, make the protein, and display it on the cell’s surface. The immune system sees the protein and learns how to make an immune response against it. This protein causes an immune response, which teaches the body how to protect itself from a specific virus by producing antibodies against that virus.

It would be false information to say that mRNA vaccines for cattle do not exist. In fact, trial studies have been conducted on cattle at some research facilities. But here is the important thing to for you to know, none of the trial vaccines are USDA approved for use in cattle. That means the mRNA technology vaccines cannot be used. If you did not see the statement from NCBA, I have included it along with additional information.

“There are no current mRNA vaccines licensed for use in beef cattle in the United States. Cattle farmers and ranchers do vaccinate cattle to treat and prevent many diseases, but presently none of these vaccines include mRNA technology.”

  • Research on mRNA vaccines for use in livestock has been ongoing for more than a decade, which suggests that at some point mRNA vaccines may be available for use in U.S. cattle. However, this will not happen before there has been sufficient research and significant layers of government review and approval.
  • Modified-live vaccines containing RNA from viruses such as bovine viral diarrhea virus (BVDV), bovine respiratory syncytial virus (BRSV), rotavirus, and coronavirus have been licensed and used by U.S. producers for many years.
  • No vaccines currently licensed in the U.S. for administration to cattle were produced using mRNA technology.
  • Currently there are no mRNA vaccines licensed for use in cattle in the U.S. New prescription vaccines in swine can use RNA of specific viruses, which is similar to mRNA vaccines, but not exactly the same.
  • Regardless of the vaccine technology, the components of vaccines are ‘digested’ or broken down by immune cells after they are given so the components do not persist in animal tissues for long periods of time.
  • Following the withdrawal times on vaccine labels helps to ensure that meat from vaccinated animals is safe to consume.

If you have any questions concerning mRNA vaccines as compared to traditional, please feel free to contact me at, 865-974-3538, lstrick5@utk.edu, or askdrlew.tennessee.edu.

Source : tennessee.edu

Trending Video

Sowing Success: Dr. Gordon Spronk's Journey with Pipestone and the Future of Swine Health

Video: Sowing Success: Dr. Gordon Spronk's Journey with Pipestone and the Future of Swine Health

Welcome back to In Swine Versation. Get ready for an enlightening journey as we delve into the remarkable story of Dr. Gordon Spronk, a founding partner at Pipestone, in our latest episode of "Sowing Success." In this episode, we'll be exploring key questions that shed light on Pipestone's evolution and the future of swine health. Here's a glimpse of what to expect:

1. Exploring Pipestone's Foundations: We'll kick off by uncovering the early vision behind Pipestone and how it has shaped the landscape for new entrepreneurs entering the field. Dr. Spronk will share insights into the core principles that have guided Pipestone's journey and how they continue to drive success today.

2. Industry-Shaping Experiences: Moving on to Dr. Spronk's impactful tenure at the National Pork Board, we'll explore his contributions to sustainability, growth accomplishments, and his vision for the future of pork production. Expect to gain insights into how Dr. Spronk's experiences have influenced the industry and what he envisions for its future.

3. Global Excellence and Growth: With Pipestone ranking second in the latest World Mega Producers ranking, we'll delve into what these impressive numbers signify and how Pipestone continues to excel on a global scale. Dr. Spronk will share his perspectives on the key factors driving Pipestone's success and its strategy for continued growth and innovation.

4. Navigating Challenges: We'll address the hot topic of Prop 12 and its implications for the industry. Dr. Spronk will provide valuable insights into the challenges and implementation issues faced by Pipestone and how the company is navigating through this complex landscape.

5. Updates on Wholestone Plant: Dr. Spronk will provide updates on the latest developments at the Wholestone plant in South Dakota, offering insights into how this initiative aligns with Pipestone's broader goals and objectives.

6. Transformative Journey of Pipestone Management: Taking a trip down memory lane, we'll explore the transformative journey of Pipestone Management since its inception in 1988. Dr. Spronk will share insights into the growth and evolution of Pipestone Management, highlighting key milestones and lessons learned along the way.

7. Defining Swine Health Success: Finally, we'll delve into Dr. Spronk's definition of swine health and its pivotal role in the success of Pipestone Management. Expect to gain a deeper understanding of the importance of swine health and how it drives Pipestone's mission and values.

Overall, this episode promises to be a thought-provoking exploration of Pipestone's journey and the future of swine health. Tune in for an engaging conversation that's sure to leave you inspired and informed about what lies ahead in the world of pork production.